Congenital Erythropoietic Porphyria: A case series in Lombok
DOI:
https://doi.org/10.33820/mdvi.v49i4.399Keywords:
porfiria eritropoetik kongenital, porfiria bulosa, porfiria kutan, uroporfirinogen III sintaseAbstract
Introduction: porphyria is a group of disorders caused by enzyme deficiency in heme synthesis pathway. Congenital erythropoietic porphyria (CEP) is an extremely rare cutaneous porphyria caused by mutations in the gene encoding uroporphyrinogen III synthase leading to accumulation of porphyrins in erythrocytes and tissues such as skin, teeth and bone resulting in hemolytic anemia, photosensitivity and erythrodontia. Case: we present two cases of CEP with typical manifestation of blistering neonatal-onset photosensitivity, erythrodontia and red-colored urine, as well as one case with hemolytic anemia. Both had no prior history of acute neurological episodes or abdominal pain that establish the cutaneous porphyria diagnosis. Pink fluorescence was visible on the teeth and urine under the Wood's lamp. Further investigations were not conducted. Discussion: the diagnosis of CEP can be established on its typical clinical manifestations and simple investigations with Wood's lamp, confirmed by examination of urine and feces porphyrins, identification of UROS or X-linked GATA 1 gene mutations. CEP management is in the form of comprehensive photoprotection and treatment with various disciplines because the clinical manifestations and severity of CEP vary in each patient. Early age of onset and severity of haematological symptoms are factors that determine poor prognosis.
Keywords: congenital erythropoietic porphyria, bullous porphyria, cutaneous porphyria, uroporphyrinogen III synthase.
Downloads
References
2. DM B, B. W. Acute hepatic porphyria. J Clin Transl Hepatol. 2015;3:17-26.
3. DM B, KE A, HL B. Porphyria. N Engl J Med. 2017;377:862-72.
4. ED P, V B, F G. Advances in understanding the pathogenesis of congenital erythropoietic porphyria. Br J Haem. 2016;173:365–79.
5. RP K, AV A, AY F, S W. Katugampola RP, Anstey AV, Finlay AY, Whatley S, et al. A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases. Br J Dermatol 2012; 167: 888–900.
6. AL E, RJ D. Congenital erythropoietic porphyria: Recent advances. Mol Genet Metab. 2019;128(3):288–297.
7. RA N, D W, MAEM, Wagenmakers GS MFE, JG. L. Neeleman RA, Wensink D, Wagenmakers MAEM, Mijnhout GS, Friesema ECH, Langendonk JG. Diagnostic and therapeutic strategies for porphyrias. The Netherlands J Med 2020; 78 (4): 149-160. Netherlands J Med. 2020;78 (4):149–60.
8. M B, S B, M S, A K. 8. Bhusal M, Bhattarai S, Shah M, Khadka A. Congenital erythropoietic porphyria: A case series of a rare uroporphyrinogen III synthase gene mutation in Nepalese patients. JAAD Case Reports 2021; 10:102-6. JAAD Case Reports. 2021;10:102–6.
9. M H, A H, Ramsay D. Congenital erythropoietic porphyria (Gunther disease) - long-term follow up of a case and review. Dermatol Online J. 2017;23.
10. VMS R, KE A. Porphyria Diagnostics – Part 1: A brief overview of the porphyrias. Curr Protoc Hum Genet. 2016;86 (17):1–26.
